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Summary
CD45 antigens are protein tyrosine phosphatases. A possible link was evaluated between expression
ofCD45 antigens on human myeloid progenitor cells (MPC) (colony-forming unit-granulocyte/
macrophage [CFU-GM], burst-forming unit-erythroid [BFU-E], and colony-forming unit-gran-
ulocyte/erythroid/macrophage/megakaryocyte [CPU-GEMM]) and regulation ofMPC by colony-
stimulating factors (CSF) (interleukin 3 [IL3], GM-CSF, GCSF, M-CSF, and erythropoietin
[Epo]), a GM-CSFAL3 fusion protein, and mast cell growth factor (MGF; a c-kit ligand) . Treatment
of cells with antisense oligodeoxynucleotides (oligos) to coons 1 and 2, but not 4, 5, or 6, of
theCD45 gene, or with monoclonal anti-CD45, significantly decreasedCFU-GM colony formation
stimulated with GM-CSF, IL3, aGM-CSFAL3 fusion protein, and GM-CSF + MGF, but not
with G-CSF or M-CSF. It also decreased GM-CSF, IL3, fusion protein, and MGF-enhanced
Epo-dependent BFU-E and CFU-GEMM colony formation, but had little or no effect onBFU-E
or CFU-GEMM colony formation stimulated by Epo alone . Similar results were obtained with
unseparated or purified (greater than or equal to one oftwo cells being a MPC) bone marrow
cells. Sorted populations of CD343+ HLA-DR's marrow cells composed of 90% MPC were
used to demonstrate capping of CD45 after crosslinking protocols . Also, a decreased percent
of CD45' cells and CD45 antigen density was noted after treatment of column-separated
CD34+ cells with antisense oligos to exon 1 of the CD45 gene . These results demonstrate that
CD45 cell surface antigens are linked to stimulation of early human MPC by IL3, GM-CSF,
a GM-CSF/IL3 fusion protein, and MGR
B
lood cells arise from rare populations of cells termed he-
matopoietic stem and progenitor cells (1) . Proliferation/
differentiation of stem/progenitor cells is regulated by an in-
teracting network of accessory cell-produced cytokines (2) .
Based on our interest in myeloid progenitor cell (MPC)t
I Abbreviations used in this paper. BFU-E, burst-forming unit-erythroid ;
CFU-GEMM, colony-forming unit-granulocyte/erythroid/macrophage/
megakaryocyte ; Epo, erythropoietin ; GM, granulocyte/macrophage; hu,
human ; LD, low density ; MGF, mast cell growth factor ; MPC, myeloid
progenitor cell; mu, murine; NALDT - , nonadherent low density T
lymphocyte-depleted fraction.
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cytokine receptors (3), in other cell surface determinants on
MPC that may be involved in cytokine-mediated myeloid cell
regulation (4), and in the molecular (5, 6) and cellular im-
munology (7, 8) oflymphoidCD45 surface antigens, we be-
came intrigued in a potential role forCD45 antigens inMPC
regulation.
CD45 antigens are protein tyrosine phosphatases (9, 10) .
They have been variously termed human leukocytecommon
antigens, murine Ly5, T-200, and B220, and are a family of
five or more glycoproteins (5, 11, 12) . Various isoforms of
CD45 are generated by alternative mRNA splicing of pri-
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lular domains are different, but the transmembrane and cy-
toplasmic segments are the same . The human CD45 gene
is encoded on chromosome 1 and has 33 exons (13, 15) . Exon-1
does not encode apeptide. Exon-2 contains the initiationATG
codon and encodes the signal peptide . Exon 3 and exons 7-15
encode the entire extracellular domain sequences common
to all CD45 isoforms. Differential usage of exons 4, 5, and
6 generate the five, and possibly eight, distinct isoforms (13,
15) . CD45 antigens have been implicated in signal transduc-
tion and lymphoid activation by specific association with
receptor molecules on T and B lymphocytes (7, 8, 16, 17) .
This led us to investigate whether CD45 antigens might be
linked to growth factor regulation of MPC .
Long-term bone marrow myeloid-initiating cells in vitro
express CD45 antigens (18), but these antigens had not been
implicated in regulatory myeloid interactions . We used mo-
lecular, cellular, and immunological approaches to determine
if CD45 surface determinants were linked to regulation of
cytokine stimulation ofhuman multipotential (colony-forming
unit-granulocyte/crythroid/macrophage/megakaryocyte [CFU-
GEMM]), erythroid (blast-forming unit-erythroid [BFU-E]),
and granulocyte/macrophage (colony-forming unit-granulo-
cyte/macrophage [CFU-GM]) progenitor cell proliferation .
This included use ofantisense oligodeoxynucleotides (oligos)
to exons oftheCD45 gene to modulate gene expression,mAbs
to framework CD45 antigens for "blocking" and crosslinking
experiments, and highly enriched populations ofMPC in cell-
sorted CD343+HLA-DR+ human bone marrow to verify
direct effects on the rare populations of MPC . The results
suggest that CD45 surface determinants onMPC are involved
in the regulation of stimulation of these cells by early acting
cytokknns : mast cell growth factor(MGF; a c-kit ligand; also
termed stem cell factor [SCF] and kit ligand [KL]) (19-23),
IIT3 (2), granulocyte/macrophage-CSF (GM-CSF) (2), and
a newly engineered GM-CSF/IIT3 fusion protein (24), but
not by the more lineage-restricted cytokknns : erythropoietin
(Epo), G-CSF, and M-CSF each alone (2) .
Materials and Methods
Cells
Human bone marrow cells were aspirated from the posterior
iliac crest after receiving informed consent from healthy donors.
Cells were separated into a low density (LD, <1.077 gm/cm 3 ) frac-
tion containing all or most of the MPC . LD cells were further
depleted of monocytes, by adherence to plastic, and ofT lympho-
cytes, by E-rosetting, but still contained all or most MPC (25) .
The nonadherent low density T lymphocyte-depleted fraction
(NALDT- ) contained <2% monocytes, as determined by non-
specific esterase staining, and T lymphocytes, as determined by anal-
ysis using CD3 antibodies and a flow cytometry system (753 ;
Coulter Electronics, Hialeah, FL) . Progenitor cells were further
isolated by cell sorting into a population of CD34"HLA-DR`
cells (25, 26) using a flow cytometry system (753 ; Coulter Elec-
tronics) . This results in a fraction with a high purity (>98%) of
CD34 cells and a highMPC cloning efficiency (>50%) but recovery
offew cells. In some experiments, unseparated marrow cells were
enriched for CD34' cells using a column separation with anti-
Treatment of Cells
Myeloid Progenitor Cell Assays
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CD34 that involves avidin-biotin linkage (27), kindly provided by
Dr. R . Berenson (Cell Pro Incorp., Bothell, WA) . This results in
a fraction with a lower purity ofCD34' cells (45-80%) and a
lowerMPC cloning efficiency (10-22%) than by flow sorting, but
in recovery of a greater number of cells .
Cells were preincubated with oligos and/or antibodies before
plating in semi-solid culture medium for assessment of MPC.
Antisense and Sense Ofgos. These were prepared by the phos-
phoramide method with no modifications made to the oligos and
are listed in Table 1 . Cells were incubated with 20-mer oligos (7-14
p,M each time) essentially as described by others for evaluation of
a different gene expression (28) . Oligos or control (McCoy's)
medium were added to cells in suspension without serum . 2 h later,
heat-inactivated (56°C for 0.5 h) FCS (HyClone Laboratories,
Logan, UT) was added at 10% (vol/vol), and the cells were left
in suspension culture . After another 15-17 h (or 6-8 h for the
CD343*HLA-DR* or CD34* column-separated cells), oligos or
control medium were added again and cells plated in semi-solid
culture medium, without washing, as described below, or cells left
in suspension and oligos or control medium added at 2, 4, and
6 d, and then plated in semi-solid medium after the seventh day
with or without additional oligos or conditioned medium .
"Blocking"and Crosslinking Experiments.
￿
These were done with
monoclonal anti-CD45 (9.4, IgG2a) (8, 29) . For "blocking", cells
were incubated with 1 jug mAb/10 5 cells at 4°C for 30 min and
then plated without washing. As a control for 9.4, an isotype-
matched controlmAb (IgG2a; Southern Biotechnology Associates,
Inc., Birmingham, AL) was used . For crosslinking, cells were in-
cubated with 1 Pg mAb/106 cells at 4°C for 30 min, washed
twice, incubated with 1 wg affinity-purified sheep anti-mouse IgG
(heavy and light chains ; Cappel Laboratories, West Chester,
PA)/106 cells at 37°C for 1 h, washed twice, and plated with or
without oligos. To assess whether crosslinking resulted in capping,
cells were exposed to FITC-conjugated anti-CD45 and then to
FITC-conjugated sheep anti-mouse IgG. To determine fluorescence
intensity and percent CD45' cells after oligo treatment, cells were
reacted with anti-CD45 conjugated to FITC (0.5 wg) or mono-
clonal anti-IgG-FITC (4.0 hg ; Coulter Immunology, Hialeah, FL) .
Flow cytometric analysis was performed using a FACScan® (Becton
Dickinson & Co., Sunnyvale, CA) . Light scatter gates were set
on the populations known from previous experiments to contain
MPC . Data analysis wasperformed using a Consort 30 (Becton
Dickinson & Co.) FACS data analysis program .
Colonyforming Unit-Granulocyte/Macrophage.
￿
Cells were plated
at designated cell concentrations in 0.3% agar (Difco Laborato-
ries, Inc ., Detroit, MI) culture (25) or 0.4% Sea Plaque Agarose
(FMC Bioproducts, Rockland,ME) culture (30) medium as previ-
ously reported . Cells were stimulated bypurified recombinant prepa-
rations of human (hu) 11,3 and GM-CSF (>4 x 10' U/mg each)
(Immunex, Corp., Seattle, WA), huG-CSF (>10' U/mg, Im-
munex Corp.), huM-CSF (>2 x 10' U/mg, lot DCP-006 from
the long form; a gift from Dr. Peter Ralph, Cetus Corp.,
Emeryville, CA), a purified huGM-CSF/I1r3 fusion protein
(PIXY321 ; Immunex Corp.) (24), and purified murine (mu)MGF
(Immunex Corp.) or by medium conditioned by the human 5637
cell line (30) . Cultures were incubated at lowered (5%) Oz ten-
sion (30) in an ESPEC Na-Oz-CO2 incubator BNP-210 (Tabai
ESPEC Corp., South Plainfield, NJ), and colonies (>40 cells/ag-gregate) and clusters (3-40/cells aggregate) scored after 7 or 14
d . Colony and cluster morphology was assessed as before (25, 30).
Burstforming Unit-Erythroidand Colortyforming Unit-Granulocyte/
Erythroid/Macrophage/Megakaryocyte .
￿
Cells were plated as above
but in 1.3% methylcellulose with recombinant Epo (1 U/ml)
(Amgen Corp., Thousand Oaks, CA) with or without 11,3, GM-
CSF, GM-CSF/111,3 fusion proteins, or MGF (26) . Cultures were
incubated for 14 d.
Statistics.
￿
Results are expressed as mean ± 1 SEM ofthree plates/
point forCFU-GM and four plates/point forBFU-E/CFU-GEMM
assays. Levels of significance were determined using student's t dis-
tribution .
Results
Influence of Antisense Oligos to CD45 Exons
on CSRdependent Colony Formation
The aim of our study was to evaluate a role for CD45 an-
tigens on growth factor-dependent proliferation of human
bonemarrowMPC by first using an antisense oligo approach
to decrease CD45 antigens on these cells. Our prior studies
with spleen cells from C57131/6-Ly5' congenic (Ly5.1+)
mice found that the sense oligo to the human equivalent of
exon 2 of the mouse CD45 gene had no effect on Ly5 an-
tigen expression, but antisense oligo to this region reduced
cell surface Ly5 antigen expression by 45-48% (p < 0.001) .
This suggested the feasibility of such an approach usinghuman
cells . Thus, normal human bone marrow cells separated into
a LD or NALDT- fraction, but containing >98% of the
MPC, were incubated in suspension with either of the oligos
to human CD45 exons listed in Table 1. Oligos were added
at 0 and 19 h, or 0, 19, 48, 96, 124, and 168 h before plating
in semi-solid agar culture medium containing maximal
amounts of5637CM (10% [vol/vol], as a source ofGM-CSF
and G-CSF [2]) or rhuGM-CSF (200 U/ml) . As shown in
Table 2, none of the oligos influenced CFU-GM colonies
formed after 7 d in semi-solidmedium in response to 5637CM,
but 41-48% significant inhibition (p <0.001) of these colo-
nies was seenwhen cells were incubated with antisense oligos
to exons 1 or 2 and scored after a 14-d incubation . No inhibi-
tion was seen with the sense oligos to exons 1 or 2, or the
antisense oligos to exons 4, 5, or 6, after 14 d in semi-solid
medium with 5637CM . Treatment with the combination of
antisense oligos to exons 1 and 2 did not further decrease
colony formation . Two additions o£ oligos (0 and 19 h) were
as effective at inhibiting MPC growth as the six additions
(0, 19, 48, 96, 124, and 168 h) (data not shown) . Since colony
formation after 7 vs . 14 d in the presence of5637CM is due
mainly to the presence ofG-CSF vs. GM-CSF, respectively,
in the 5637CM (2), cells were also grown in the presence
ofrhuGM-CSF, with day 14 colony results equivalent to those
using 5637CM (Table 2) . The results were similar whether
LD or NALDT- cells were used . To rule out the possibility
that the differences were due only to the day of scoring (GM-
CSF being able to stimulate few or no colonies after only
7 d of incubation in semi-solid medium), NALDT - bone
marrow cells were incubated in suspension with two addi-
tions ofcontrol medium, sense oligos to exon 1 or antisense
oligos to exons 1 and 2, before plating in semi-solid agarose
medium and incubation for 14 d with plateau concentrations
of either rhuGM-CSF (200 U/ml), rhuII,3 (200 U/ml), rhuG
CSF (200 U/ml), or rhuM-CSF (2,000 U/ml) . As seen in
Fig. 1, antisense oligos to exons 1 and 2, but not sense oligos
to exon 1, greatly decreased (p < 0.001) day 14 colony and
cluster formation stimulated with rhuGM-CSF and rhuIL3,
but had no effect on colony and cluster formation stimulated
withrhuG-CSF orrhuM-CSF. Colonies and clusters formed
in the presence of GM-CSF or IL-3 were -60% granulo-
cyte/macrophage (GM), 30% macrophage (M), and 10%
granulocyte (G), while those formed in the presence of
G-CSF or M-CSF were, respectively, >97% G or M . No
colonies or clusters formed in the absence of CSF.
Antisense oligos were also evaluated for effects on Epo (1
U/ml)-dependent BFU-E colony formation and on rhuGM-
CSF- or rhuIL3-enhanced Epo-dependent BFU-E colony for-
mation in semi-solid methylcellulose medium (average of two
to six experiments with LD or NALDT - cells) . Only an-
tisense oligos to exons 1 and 2 slightly (-26 ± 6 and -16
± 7%), but significantly (p< 0.05) decreased Epo-stimulated
BFU-E colony formation . RhuGM-CSF and rhuIL3
significantly enhanced (+70 ± 12 and +57 ± 3 ; p < 0.001)
Oligonucleotides were prepared by the phosphoramidite method . No modifications were made to Oligos. Hu, human ; mu, murine .
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Table 1 . Antisense and Sense Oligodeoxynucleotides to Exons of the Human and Mouse CD45 Gene
5' end 3' end
Antisense HuExon-1 TCA GAC GAG GAA CAA TTT CC
Antisense HuExon-1 AAC CAC TTG CTA GCT GCA TG
Antisense HuExon-2 TCT GTG TCC AGA AAG GCA AA
Sense HuExon-1 GGA AAT TGT TCC TCG TCT GA
Sense HuExon-2 TTT GCC TTT CTG GAC ACA GA
Antisense HuExon-4 GAG TAG GTA AGG GGT CAC TT
Antisense HuExon-5 GCA GAG GGC GTC TGC GAG TC
Antisense HuExon-6 AGG TAA GGC AGC AGA GCT GTTable 2 .
￿
Influence of Antisense and Sense Oligodeoxynucleotides to Exons ofCD45 Genes on Colony Formation by CFU-GM
Epo-dependent BFU-E colony formation, and this increase
was completely suppressed (-26 ± 4 and -20 ± 5 with
IIr3, and -39 ± 2 and -39 ± 6% withGM-CSF; p<0.001)
by preincubation of cells with antisense oligos to exons 1
and 2, but not with antisense oligos to exons 4, 5, and 6,
or with sense oligos to exons 1 and 2 . The combination of
antisense oligos to exons 1 and 2 did not decrease colony for-
mation to a greater extent than that seen with antisense oligos
to either exon 1 or exon 2 . Results were similar whether LD
or NALDT- cells were used .
Influence ofCD45 mAbs on CSF-dependent
Colony Formation
"Blocking" Experiments.
￿
As another approach, NALDT -
bone marrow cells were preincubated with either control
medium, anti-CD45 (9.4) or an isotype IgG2a)-matched con-
trol antibody (each at 1 kg/105 cells) at 4°C for 30 min be-
fore plating, without washing, in semi-solid agarose medium
with different CSFs. As shown in Fig . 2, preincubation of
cells with anti-CD45 monoclonal, but not with isotype-
matched control, significantly (p < 0.001) suppressed colony
and cluster formation by CFU-GM stimulated withrhuGM-
CSF or rhuIIJ3, but not withrhuGCSF orrhuM-CSF . Similar
experiments evaluated CD45 mAb on colony formation by
BFU-E andCFU-GEMM (Fig. 3) . CD45 antibody pretreat-
ment had no effect on colonies formed in the presence of
Epo alone, but it completely ablated Epo-dependent BFU-E
andCFU-GEMM colony formation enhanced by rhuIIT3 or
rhuGM-CSF.
Crosslinking Experiments with and without Subsequent Oligo
Treatment. As a third approach to linking CD45 antigens
with regulation of MPC proliferation, NALDT- marrow
cells were treated with nonblocking concentrations ofmono-
Percent change colony formation from control
Day 7 CFU-GM
￿
Day 14 CPU-GM
￿
Day 14 CFU-GM
Oligodeoxynucleotides
￿
(10% [vol/vol] 5637 CM)
￿
(10% [vol/vol] 5637 CM)
￿
(200 U rhuGM-CSF)
Results shown averages for a total of three to six separate experiments each using LD or NALDT- normal human bone marrow cells . Control
numbers of day 7 colonies stimulated with 5637 CM, day 14 colonies stimulated with 5637 CM, and day 14 colonies stimulated with GM-CSF,
respectively, ranged from 33 to 105, 32 to 125, and 26 to 135 . The results were similar regardless of which antisense oligo to exon 1 was used
(see Table 1) .
p < 0.001 .
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clonal anti-CD45 (9.4; 1 Ftg/106 cells) under crosslinking
conditions for CD45 antigens . Cells were preincubated with
CD45 antibody for 30 min at 4°C, washed, and incubated
at 37°C for 1 h, with sheep anti-mouse IgG (1 P,g/106
cells) . Preliminary experiments had demonstrated >65% cap-
ping of CD45 on a mouse T cell line using FITC-labeled
monoclonal anti-Ly-5 (CD45) under these conditions . In the
present experiment (Fig . 4), treated cells were cultured in
semi-solid agarose medium in the presence of different CSFs
and assessed for CFU-GM colony formation . When cells were
treated with anti-CD45 and a second antibody (designated
capping), there was a significant decrease (p < 0.001) in
Figure 1 .
￿
Comparative influences ofrhuGM-CSF, rhuII,3, rhuGCSF,
and rhuM-CSF on inhibition ofCFU-GM colony and cluster formation
by antisense oligos to exons 1 and 2 ofthe human CD45 gene . NALDT-
cells (2.5 x 10 4) were plated in semi-solid agarose culture medium .
Results show one representative of three similar experiments.
Antisense Ex-1
Antisense Ex-2
Antisense Ex-1 and -2
Sense Ex-1
Sense Ex-2
+0.3 ±
-0.3 ±
ND
ND
-6±3
4
2
-41 ± 4'
-46 ± 7'
-48 ± 2"
+ 1 ± 3
-6±2
-55
-53
-51
0
± 6`
± 6"
± 5
± 4
-3±2
Antisense Ex-4 - 5 ± 3 - 5 ± 4 -0.2 ± 4
Antisense Ex-5 + 6 ± 3 -1 ± 3 + 5 ± 4
Antisense Ex-6 - 0.3 ± 3 0 ± 3 + 1 ± 3Figure 2 .
￿
Comparative influences ofrhuGM-CSF, rhuIL3, rhuG-CSF,
and rhuM-CSF on inhibition ofCFU-GM colony and cluster formation
by "blocking" concentrations of CD45 mAb (9.4; 1 ug/105 cells) .
NALDT - cells (2.5 x 104) were plated in semi-solid agarose culture
medium . Results show one representative of three similar experiments .
(") Daycolonies and clusters were scored. Scoring GCSF colonies on day
14 did not change results: no inhibition was seen (data not shown) .
colony formation stimulated with rhuIIr3 or rhuGM-CSF
(Fig. 4, A and B), but not with rhuG-CSF or rhuM-CSF
(Fig. 4, C and D) . Treatment with anti-CD45 only, the
isotype-matched control, or second antibody only did not
decrease CSF-stimulated colony formation (data not shown) .
Similar results were noted forBFU-E and CFU-GEMM (data
not shown), in that conditions of crosslinking, but not other
conditions (anti-CD45 alone, or second antibody alone), com-
pletely suppressed rhuGM-CSF (200 U/ml)- or rhuIIr3 (200
U/ml)-enhanced colony formation by Epo (1 U/ml)-dependent
BFU-E- andCFU-GEMM . That CD45 capping actually oc-
curred on MPC under crosslinking conditions was assessed
451
￿
Broxmeyer et al .
on NALDT - CD343+HLA-DR+ normal human bone
marrow cells. In this experiment, 49 ± 1 CPU-GM-, 27
± 3 BFU-E-, and 14 ± 3 CFU-GEMM colonies formed
per 100 cells plated in the presence of a combination of Epo
(2 U/ml), rmuMGF (50 ng/ml), rhuGM-CSF (100 U/ml),
and rhuIIr3 (100 u/ml) . In this population, capping ofCD45
was apparent on -50% of the cells 1 h after addition ofFITC-
labeled sheep anti-mouse IgG at 37°C . No capping was ap-
parent with only the second antibody . Capping was also ap-
parent on 35-50% of CD34+ column-separated human
bone marrow cells (two experiments with MPC cloning
efficiencies of 10-22%) .
The above results suggested involvement ofCD45 antigens
on rhuGM-CSF- or rhuIIr3-stimulated CFU-GM, and H,3-
and GM-CSF-enhanced Epo-dependent BFU-E and CFU-
GEMM colony formation, but since the oligo, "blocking",
and crosslinking treatments only resulted in partial decrease
in colonies, subpopulations ofMPC were implicated in this
association . To determine if CSF-stimulated colony forma-
tion could be further reduced, NALDT - bone marrow cells
were first treated with anti-CD45 plus second antibody and
then immediately incubated in suspension culture with con-
trol oligos (antisense to exon 5 or sense to exon 1) or active
oligos (antisense to exons 1 or 2), added twice within 19
h, before plating cells in agarose culturemedium with different
CSFs (Fig . 4) . Treatment for crosslinking (designated "cap-
ping" in the Fig . 4) or with antisense oligos to exon 1 or
2 significantly (p < 0.001) reduced rhuIIr3 (Fig. 4 A) and
rhuGM-CSF (Fig. 4 B), but not rhuGCSF (Fig. 4 C) or
rhuM-CSF (Fig. 4 D) stimulated CFU-GM colonies and
clusters. Additionally, combination pretreatment (crosslinking
and antisense oligos to exons 1 or 2) did not result in any
further inhibition ofrhuIIr3- or rhuGM-CSF-stimulated colo-
nies and clusters (Fig . 4, A and B) . Combination treatment
had no effect on rhuG-CSF- or rhuM-CSF-stimulated colo-
nies and clusters (Fig . 4, C and D) . Asshown in Fig. 5, similar
results were noted withBFU-E andCFU-GEMM . The data
Figure 3 .
￿
Comparative influences of rhul1.3
and rhuGM-CSF on inhibition of Epo-stimu-
lated BFU-E andCPU-GEMM colony forma-
tion by "blocking" concentrations of CD45
mAb (9.4 ; 1 jug/105 cells). NALDT- cells
(2 .5 x 10 4) were plated in semi-solid methyl-
cellulose culture medium. Results show one
representative of three similar experiments.Figure 4.
￿
Comparative influence of CSF on inhibition ofCFU-GM colony and cluster formation by treatment of cells with CD45 mAb (1 Wg/106
cells) plus a second antibody under conditions conducive for crosslinking of CD45 antigens and then with antisense oligos to exons 1 and 2 of the
human CD45 gene . Treated NALDT - cells were then plated at 2 .5 x 104/ml in semi-solid agarose culture medium with (A) rhulIr3 ; (B) rhuGM-
CSF; (C) rhuG-CSF ; and (D) rhuM-CSF and cultures scored after 14 d of incubation . Results show one representative of two complete experiments
with similar results.
suggest that CD45 antibody and CD45 antisense to exons
1 and 2 act on the same population of cells .
Comparative Influences of a GM-CSF/IL3 Fusion
Protein or MGF on Colony Formation of Oligo- or
Anti-CD45pretreated Bone Marrow Cells
GM-CSF and IL3 are early acting CSFs compared to the
more lineage-restricted effects ofG-CSF andM-CSF (2, 26) .
To further evaluate the possibility that CD45 involvement
ofMPC regulation was restricted to early populations ofMPC,
other early acting cytokines were used . As seen in Fig. 6,
theGM-CSF/IL3 fusion protein stimulatedmoreCFU-GM
colonies than GM-CSF, IL3, or the combination of GM-
CSF plus IL3 . Preincubation of cells with antisense oligos
to exons 1 and 2, but not with sense oligos to exon 1 or
antisense oligos to exon 4, decreased colony formation stimu-
lated with GM-CSF, IL3, GM-CSF plus IIL3, and the GM-
CSF/IL3 fusion protein, but did not influence colony for-
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mation stimulated by G-CSF. Inhibition was greatest with
cells stimulated with the fusion protein. Both MGF and the
fusion protein were compared, at maximal concentrations,
for effects on BFU-E (Fig. 7 A) and CFU-GEMM (Fig.
7 B) colony formation by NALDT- marrow cells pretreated
with anti-CD45, or an isotype-matched antibody control.
Pretreatment of cells with anti-CD45, but not with the iso-
type control, inhibited enhanced Epo-dependent colony for-
mation by cells stimulated with 11,3, the fusion protein, or
MGF ; themore colonies that formed in response to cytokine,
the greater the degree ofsuppression with anti-CD45 . Similar
effects were seen when CFU-GM were evaluated (data not
shown) . MGF enhances size, as well as number of colonies
formed (19-23) . Colonies formed in the presence of MGF
weremuch larger than those formed in the absence ofMGF.
Pretreatment of cells with antisense oligo to exons 1 or 2
or with anti-CD45 greatly reduced the size ofcolonies formed
in the presence ofMGF, in most cases to that seen in theFigure 5 .
￿
Comparative influences of rhuIL3 andrhuGM-CSFon inhi-
bition ofBFU-E colony formation by treatment ofcells with CD45mAb
(1 jig/106 cells) plus a second antibody under conditions conducive for
crosslinking of CD45 antigens and then with antisense oligos to exons
1 and2 of the human CD45 gene. NALDT- cells (2 .5 x 104/ml) were
plated in semi-solid methyloellulose culture medium . Results show one
of two similar experiments.
absence of MGF (data not shown) . This was not observed
with control oligos or the isotype-matched control antibody.
Effects on Highly Enriched MPC
The antigenic density profile for CD45, shown in Fig . 8,
demonstrates that treating CD34+ column-enriched human
bone marrow MPC with antisense oligos to exon 1 of the
CD45 gene decreases within 6 h the density expression of
CD45, compared to cells treated with sense oligos to exon
1. This fraction ofCD34 cells had a cloning efficiency of22%
for CFU-GM, BFU-E, andCFU-GEMM in the presence of
Epo, MGF, IIr3, andGM-CSF, and the antigenic profile was
generated from the light scatter portion of cells known from
previous experiments to contain the MPC. Colony assay as-
sessment of these treated cells demonstrated that oligo treat-
ment with antisense to exon 1 reduced CFU-GM, BFU-E,
and CFU-GEMM colonies, respectively, by 81, 76, and 87%
(p <0.005) compared to cells treated with the sense oligos
to exon 1 or with McCoy's medium . Other non-MPC-
containing portions of the column-separated cells responded
in a manner similar to the MPC-gated population in terms
of decreased CD45 antigen density when cells were treated
with antisense oligos to exon 1 compared to sense oligos .
52% of cells treated with antisense oligo to exon 1 and gated
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for in the MPC-containing region were positive for CD45,
while 78% of cells treated with sense oligos in this gated
area were CD45+ .
To further establish that functional effects were direct ones
on MPC, NALDT - CD343+HLADR+ populations of
marrow cells (23, 25, 26) were tested (Fig. 9) . The optimal
cloning efficiency in these experiments was 50% for CFU-
GM plus BFU-E when 125 cells were plated in the presence
ofEpo (1 U/ml) and 10% (vol/vol) 5637CM . In this popu-
lation, treatment of cells with antisense oligos to exons 1
and 2 (Fig. 9A) or anti-CD45 (Fig. 9 B) suppressed colony
formation stimulated by II73, GM-CSF, or MGF. This sub-
stantiated that the effects of antisense oligos and anti-CD45
were directly on the MPC and not mediated by accessory cells.
Discussion
CD45 antigenic determinants have previously been impli-
cated in lymphocyte activation and signal transduction (7,
8, 16, 17) . The results presented herein now link these an-
tigens with myelopoietic regulatory events . A number of ap-
proaches lead us to conclude that CD45 antigens on human
MPC are involved in the regulation of stimulation of these
cells by early acting cytokines such as GM-CSF, IIr3, aGM-
CSF/II73 fusion protein, and MGF, but not by the more
lineage-restricted growth factors (Epo, G-CSF, or M-CSF) .
The results also suggest that CD45 involvement reflects effects
primarily in earlier, more immature progenitors(CFU-GEMM
and subpopulations ofBFU-E and CFU-GM), rather than
in more mature and lineage-restricted progenitors (CFU-G
and CFU-M) . The approaches used to elucidate a role for
CD45 in myeloid cell regulation included use of: (a) antisense
oligos to exons of the CD45 gene: (b) "blocking" experi-
ments withmAb to CD45 antigenic determinants : (c) cross-
linking experiments with anti-CD45 and sheep anti-mouse
IgG ; and (d) combined crosslinking and antisense oligo ex-
periments. Results with LD and NALDT - cells were
confirmed using enriched populations of MPC in CD34+
column-separated and highly enriched populations ofMPC
in NALDT--sorted CD343+HLADR+ cells .
In the first case, antisense oligos to exons 1 and 2 of the
CD45 gene, but not sense oligos to exons 1 and 2, or an-
tisense oligos to the alternative splicing exons 4, 5, and 6,
decreased colony formation of human marrow CFU-GM
stimulated byGM-CSF and Ilr3, alone and in combination,
by a potent GM-CSF/11173 fusion protein, and by GM-CSF
plus MGF, but not by G-CSF or M-CSF. The greater the
stimulation, the more apparent the inhibition . Also, antisense
oligos to exons 1 and 2, but not sense oligos to exon 1 and
2, or antisense oligos to exons 4, 5, and 6, completely sup-
pressed the enhanced Epo-dependent BFU-E, and most of
the Epo-dependent CFU-GEMM colony formation noted in
the presence of IIr3, GM-CSF, theGM-CSF/II73 fusion pro-
tein, and MGR Oligo pretreatment had little or no effect
on the more mature populations ofBFU-E stimulated only
in the presence ofEpo. An enriched population ofCD34 +
column-separated cells gated in the MPC-containing region
was used to directly demonstrate that the antisense to exon 1Figure 6 .
￿
Comparative influences of rhuGM-CSF, rhull*3, rhuGM-CSF plus rhuIl.3, rhuGM-CSF/IL3 fusion protein, and rhuGCSF on inhibition
ofCFU-GM colony formation by antisense oligodeoxynucleotides to exons 1 and 2 of the human CD45 gene. Cells were plated in semi-solid agarose
culture medium. Results show one of three similar experiments .
decreased numbers ofCD45 cells as well as density distribu-
tion ofCD45 antigens. Incomplete suppression ofCD45 sur-
face antigens in this case probably reflects the turnover rate
ofCD45 antigens (31) . The possibility that the antisense oligos
made to exons 1 and 2 of the CD45 gene were recognizing
non-CD45 genetic material and decreasing production ofnon-
CD45 proteins involved in myeloid cell regulation is consid-
ered highly unlikely. Suppression ofMPC proliferation was
attained with three different and nonoverlapping complemen-
tary oligos (20 mers to exons 1 and 2 of the CD45 gene) .
Furthermore, the oligo results were substantiated by anti-
body "blocking" and crosslinking experiments .
In the second case, mAb to framework CD45 antigens,
when used at relatively high concentrations (1 Ftg/105 cells),
but not isotype-matched controls, decreased colony forma-
tion of CFU-GM stimulated by GM-CSF, ID3, the GM-
CSF/IIr3 fusion protein, and GM-CSF plus MGF, but not
by G-CSF or M-CSF. Antibody to CD45 also completely
blocked IIr3, GM-CSF, GM-CSF/ID3 fusion protein, and
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MGF enhancement of Epo-dependent BFU-E and CFU-
GEMM colony formation, but it had no effect on colonies
stimulated by Epo only. These results thus duplicate those
seen with antisense oligos to exons 1 and 2 ofthe CD45 gene,
although it is unclear at this time how the CD45 antibody
inhibition is mediated. Two possibilities include blocking an
interaction of a cytokine-receptor complex with CD45 an-
tigens on the surface, or a downmodulating proliferative re-
sponse signaled through a CD45 antibody-CD45 surface an-
tigen complex .
In the third situation, monoclonal anti-CD45, when used
at lower, non-"blocking" concentrations (1 jAg/106 cells),
but in combination with a second antibody under crosslinking
conditions, resulted in comparable inhibition of GM-CSF,
IIr3, GM-CSF/IIr3 fusion protein, and MGF stimulated
colony formation of CFU-GM, BFU-E, and CFU-GEMM
to that notedwhen cells were pretreated with antisense oligos
to exons 1 or 2 of the CD45 gene or with "blocking" con-
centrations of anti-CD45 . Neither theCD45 antibody itselfFigure 7 .
￿
Comparative influences ofrhulIT3, rhuGM-CSF/IL3 fusion
protein, and rmuMGF on inhibition of Epo-stimulated BFU-E (A) and
CFU-GEMM (B) colony formation by monoclonal anti-CD45 . NALDT -
cells were plated in methylcellulose. Two different experiments are shown
each in A and B .
(at 1 Fig/106 cells), nor the second antibody itself resulted
in reduced colony formation, and the isotype control plus
second antibody did not suppress colony formation. That
crosslinking resulted in actual capping was demonstrated with
a population of sorted CD343+HLA-DR+ that contained
90% MPC .
To test the possibility that lack of complete suppression
of colony formation of MPC was due to incomplete treat-
ment to decrease both CD45 surface antigens and CD45 an-
tigen expression, cells were first treated with CD45 antibody
plus a second antibody to crosslink CD45 antigens, and the
cells then pretreated with antisense oligos to exons 1 or 2
of the CD45 gene to decrease expression of this gene and
thus subsequent CD45 protein production . This combina-
tion of procedures did not result in further inhibition be-
yond that seen with either procedure itself.
The use of highly enriched populations of MPC in the
CD34'+ HLADR+ fraction of sorted NALDT - cells, where
at least one of two cells was a MPC, confirms that the oligo
and antibody approaches had a direct effect on MPC, since
the results were equivalent to that seen with unseparated bone
marrow. Receptor genes for GM-CSF (32), ID3 (33), MGF
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Figure 8 .
￿
Influence of sense and antisense oligos to exon 1 ofthe CD45
gene on CD45 expression ofCD34+ column-separated cells. (A) Dot plot
of forward light scatter (FSC) vs . side scatter (SSC) of column-separated
cells. The gated area reflects fraction known from previous experiments
to contain myeloid progenitor cells. (B) CD45 antigenic profile of the gated
subpopulation ofCD34 column-separated cells. Each histogram represents
-9,000 events.
(c-kit ligand) (19-21), and Epo (34) are known, making it
clear thatCD45 antigens are not acting as the specific receptor
for this diverse group of cytokines. However, CD45 mole-
cules do appear to be associated with the action of these
cytokines, suggesting that proliferative signals of these cyto-
kinesmay share common transducing pathways . In this con-
text, the following information may be of relevance . In lym-
phocytes, CD45 expression is required for antigen-induced
proliferation of T cell clones or TCR complex (CD3/Ti)-
induced calcium mobilization (16, 35) . CD45 crosslinking
causes inhibition of phosphatidyl-inositol specific phospho-
lipase C (PI-PLC) activation in T cells (8, 17, 36) . The
PI-PLC-activated CD3/Ti stimulation requires tyrosine phos-
phorylation (37), and CD45 ligation prevents tyrosine phos-
phorylation of specific substrates during eitherCD2- or CD3-
mediated activation (17) . Stimulation ofsome of the receptors
studied in the present report, including those for IL3, GM-
CSF, and MGF, induces rapid tyrosine phosphorylation of
cellular substrates (38) . Phospholipase C y can be activated
as one of these substrates by epidermal growth factor andplatelet-derived growth factor receptors (39, 40) . The data
presented here suggest that CD45 and its associated tyrosine
phosphatase activity may interact with the tyrosine phosphory-
lation cascade induced after growth factor binding to receptors
on MPC . Since T cell, CD2, CD4, and CD8 antigens have
been linked with CD45 antigens and associated with internal
membrane tyrosine-protein kinase p56kk, and CD45 phos-
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Figure 9 .
￿
Comparative influences of
rhull,3, rhuGM-CSF, and rmuMGF in
the presence of Epo on inhibition of
CFU-GM and BFU-E colonyformation
by CD34 3 *HLA-DR' marrow cells
pretreated with oligos to exons of the
CD45 gene (A) and antibody toCD45
antigens (B) .
photyrosine phosphatase activates T cell tyrosine protein ki-
nase p56kk (16, 37, 41-43), it is possible that this phos-
phoprotein (p56'ck ) or other src family kinases may also be
involved in the regulation ofMPC proliferation by early acting
cytokines . Testing these possibilities will probably require use
of established factor-dependent cell lines whose prolifera-
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